Exhale

The official blog of the Lung Institute.

The Effects of Altitude on Lung Disease

10 Dec 2014
| Under COPD, Emphysema, Lung Disease, Related Conditions | Posted by
| 18 Comments
The Effects of Altitude on Lung Disease

Traveling to high altitudes can be both exciting and scary for those that have been diagnosed with a lung disease. On one hand you want to experience the thrills of a new environment, but on the other you might feel restricted by your current condition. This is just one example of the types of problems that lung disease patients have to face constantly. If you are considering traveling by or visiting a place in higher altitudes, there might be a few things you want to consider if you have a lung disease. These are the effects of altitude on lung disease.

What Happens to Your Lung Disease at High Altitudes?

Believe it or not, you don’t have to climb to the top of Mt. Saint Helens or journey through the Smokey Mountains to experience the changes in altitude. Many people plan trips to higher altitudes without even realizing the effect that it will have on them. This point rings true with people who have been diagnosed with a lung disease. So how do you know if the high altitude is effecting you or if it is just your lung disease flaring-up? Here is what we found out.

In a study from 2006, researchers decided to see if the effects of a higher altitude had a negative or positive effect on patients that were already diagnosed with a pre-existing lung disease. After several months of studying patients with various lung diseases (asthma, COPD, emphysema, etc…), researchers learned that some patients had a much harder time acclimating to the higher altitude due to the thinner air. Some people with pre-existing lung disease also showed signs of increased symptoms and the need for more oxygen. Of course, this study does mention that more time and research is needed to test the effects of altitude on lung disease.

The Institute for Altitude Medicine also presented some interesting findings on the effects of altitude on certain lung diseases. According to the website, people with asthma actually fair better in the higher altitude. This is because of the thinner atmosphere and a lesser presence of allergens. The same is not true for COPD patients. The Institute mentions that a study done in New Mexico and Utah showed increased death rates in people with emphysema that lived in higher altitudes, stating that COPD patients do better in lower altitudes. Traveling to these higher altitudes is possible though with a little time and planning.

What Can I Do Before Traveling to Higher Altitudes?

If you are traveling by plane or going up to higher altitude with a lung disease, it is possible to enjoy the benefits of your trip. We’ve compiled a few tips to get you ready for the higher environment:

  • Know Your Destination – Evaluate where you are going ahead of time and see if your destination is in a higher climate. The website org just does that!
  • Visit Your Doctor – Obviously a no brainer, but check with your doctor before any trip. Discuss treatments and methods that will allow you to adjust better in the thinner atmosphere.
  • Be Aware – Keep track of your symptoms and any warnings that you may experience. Watch what you eat and drink to see how you react during your time in the upper altitudes. Looking out for altitude sickness is also advised.
  • Take Your Time – Take your time and adjust accordingly. It can usually take a person between 1 to 3 days to adapt to a new environment.

Lung disease doesn’t have to restrict your quality of life. If you or a loved one is interested in cellular therapy for lung disease, then contact us at the Lung Institute to learn more or call (800) 729-3065 today.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.